Scintigraphic Evaluation of a New Capsule-Type Colon Specific Drug Delivery System in Healthy Volunteers
- 1 May 1998
- journal article
- clinical trial
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 87 (5) , 531-535
- https://doi.org/10.1021/js9704588
Abstract
Colonic drug delivery is intended for local or systemic therapies. The lack of predictive in vitro or animal model leads to considerable time delays in colonic product development. The objective of this scintigraphic study was to provide "proof of concept" for a novel capsule-type colonic delivery system (Colon-Targeted Delivery Capsule) in healthy volunteers. The human data validates the design concept behind the release mechanism, in that capsule disintegration, and hence drug release, did not start until 5 h after gastric emptying, irrespective of whether the product was administered to fasted or fed subjects. However, the potential for prolonged gastric residence for large enteric coated products intended for intestinal targeting was also observed; overall, the study provides a focus for subsequent product development and highlights the role of scintigraphy in dynamically visualizing the drug delivery process.Keywords
This publication has 22 references indexed in Scilit:
- An evaluation of pectin as a carrier for drug targeting to the colonJournal of Controlled Release, 1993
- Gastrointestinal transit of a matrix tablet formulation: comparison of canine and human dataInternational Journal of Pharmaceutics, 1993
- Characterization of colonic transit of nondisintegrating tablets in healthy subjectsDigestive Diseases and Sciences, 1993
- Colonic transit of different sized tablets in healthy subjectsJournal of Controlled Release, 1993
- Azo polymers for colon-specific drug deliveryInternational Journal of Pharmaceutics, 1992
- The role of γ-scintigraphy in oral drug deliveryAdvanced Drug Delivery Reviews, 1991
- Microbially controlled drug delivery to the colonBiopharmaceutics & Drug Disposition, 1990
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Gastrointestinal Transit and Concomitant Absorption of Verapamil from a Single-Unit Sustained-Release TabletDrug Development and Industrial Pharmacy, 1987
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986